Core Laboratories Inc. (CEI.F)
| Previous close | 20.30 |
| Open | 20.00 |
| Bid | 0.00 x 10000 |
| Ask | 0.00 x 10000 |
| Day's range | 20.00 - 20.30 |
| 52-week range | 15.30 - 23.35 |
| Volume | |
| Avg. volume | 2 |
| Market cap | 949.963M |
| Beta (5Y monthly) | 2.43 |
| PE ratio (TTM) | 42.29 |
| EPS (TTM) | 0.48 |
| Earnings date | 30 Jan 2024 - 05 Feb 2024 |
| Forward dividend & yield | N/A (N/A) |
| Ex-dividend date | N/A |
| 1y target est | 30.65 |
PR NewswireCORE LAB REPORTS FIRST QUARTER 2024 RESULTS
Core Laboratories Inc. (NYSE: "CLB") ("Core", "Core Lab", or the "Company") reported first quarter 2024 revenue of $129,600,000. Core's operating income was $8,600,000, with diluted earnings per share ("EPS") of $0.07, all in accordance with U.S. generally accepted accounting principles ("GAAP"). Operating income, ex-items, a non-GAAP financial measure, was $14,900,000, yielding operating margins of 12%, and EPS, ex-items, of $0.19. During the first quarter of 2024, the Company recorded: 1) appr
- PR Newswire
CORE LABORATORIES' FIRST QUARTER 2024 WEBCAST AT 7:30 A.M. CDT / 8:30 A.M. EDT ON APRIL 25, 2024
Core Laboratories (NYSE: "CLB") will broadcast its first quarter 2024 conference call over the Internet at 7:30 a.m. CDT / 8:30 a.m. EDT on April 25, 2024.
PR NewswireCORE LAB REPORTS FOURTH QUARTER AND FULL YEAR 2023 RESULTS
Core Laboratories Inc. (NYSE: "CLB") ("Core", "Core Lab", or the "Company") reported fourth quarter 2023 revenue of $128,200,000. Core's operating income was $14,600,000, with diluted earnings per share ("EPS") of $0.14, all in accordance with U.S. generally accepted accounting principles ("GAAP"). Operating income, ex-items, a non-GAAP financial measure, was $15,000,000, yielding operating margins of 12%, and EPS, ex-items, of $0.19. The Company's fourth quarter 2023 effective tax rate was nega
